Japan Academia Progresses Novel Melanoma Drug Despite Pharma 'Reluctance'

Promising Phase II Results

 
• By Lisa Takagi
  
National funding and an original research collaboration platform by dermatologists made the Japanese P2 successful.
National funding and an original research collaboration platform by dermatologists made the Japanese P2 successful. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia